Top

Journal of Thrombosis and Thrombolysis

Published in:

01-11-2020 | Acute Pulmonary Embolism

Long lasting hypercoagulability after subclinical COVID-19

Authors: Paolo Ferroli, Chiara Villa, Andrea Ciuffi, Guido Gubertini, Morgan Broggi

Published in: Journal of Thrombosis and Thrombolysis | Issue 4/2020

Excerpt

During COVID-19 pandemic emergency, a patient with a previous undiagnosed subclinical COVID-19 underwent urgent surgery for removal of a big intracranial tumor.
The patient developed severe APE secondary to atrial catheter-related thrombosis in the post-craniotomy clinical course.
Previous COVID-19 is suspected to be the main cause of the prothrombotic status of this patient, otherwise healthy and without any other risk factor for DVT/APE.
The temporal evolution of the hypercoagulability state in COVID-19 is still unknown.
Special attention is required when planning major surgical procedures in patients with previous COVID-19.

…

Yin S, Huang M, Li D et al (2020) Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. https://doi.org/10.1007/s11239-020-02105-8CrossRefPubMedPubMedCentral

Li T, Lu H, Zhang W (2020) Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 9(1):687–690CrossRefPubMed

Zhang Y, Cao W, Xiao M et al (2020) Clinical and coagulation characteristics of 7 patients with critical COVID-2019 pneumonia and acro-ischemia. Zhonghua Xue Ye Xue Za Zhi 41:E006PubMed

Ye Z, Zhang Y, Wang Y et al (2020) Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review. Eur Radiol. https://doi.org/10.1007/s00330-020-06801-0CrossRefPubMedPubMedCentral

Pan F, Ye T, Sun P et al (2020) Time course of lung changes on chest CT during recovery from 2019 Novel Coronavirus (COVID-19) pneumonia. Radiology. https://doi.org/10.1148/radiol.2020200370CrossRefPubMedPubMedCentral

Ruggiero A, Screaton NJ (2017) Imaging of acute and chronic thromboembolic disease: state of the art. Clin Radiol 72(5):375–388CrossRefPubMed

Burns KE, McLaren A (2008) A critical review of thromboembolic complications associated with central venous catheters. Can J Anaesth 55(8):532–541CrossRefPubMed

Dai W, Zhang H, Yu J et al (2020) CT imaging and differential diagnosis of COVID-19. Can Assoc Radiol J. https://doi.org/10.1177/0846537120913033CrossRefPubMedPubMedCentral

Gao Y, Li T, Han M et al (2020) Diagnostic utility of clinical laboratory data determinations for patients with severe COVID-19. J Med Virol. https://doi.org/10.1002/jmv.25770CrossRefPubMedPubMedCentral

Title: Long lasting hypercoagulability after subclinical COVID-19
Authors: Paolo Ferroli
Chiara Villa
Andrea Ciuffi
Guido Gubertini
Morgan Broggi
Publication date: 01-11-2020
Publisher: Springer US
Keywords: Acute Pulmonary Embolism
Computed Tomography
Acute Pulmonary Embolism
Computed Tomography
Acute Pulmonary Embolism
SARS-CoV-2
COVID-19
Central Venous Catheter
Published in: Journal of Thrombosis and Thrombolysis / Issue 4/2020
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI: https://doi.org/10.1007/s11239-020-02215-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long lasting hypercoagulability after subclinical COVID-19

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

The Impact of platelet–fibrin clot strength on occurrence and clinical outcomes of peripheral artery disease in patients with significant coronary artery disease

How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report

Low prevalence of JAK2 V617F mutation in patients with thrombosis and normal blood counts: a retrospective impact study

Assessment of the attitude, awareness and practice of periprocedural warfarin management among health care professional in Qatar. A cross sectional survey

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019

Loop-mediated isothermal amplification (LAMP)-based method for detecting factor V Leiden and factor II G20210A common variants

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page